16 completed, 4 recruiting, 3 withdrawn, 2 not yet recruiting. 28 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 28 | Completed 16, Recruiting 4, Withdrawn 3, Not yet recruiting 2, Unknown 2, Terminated 1 |
Follow Urinary Incontinence, Urge: new trials by email Literature Review of Urinary Incontinence, Urge trials Research Report on Urinary Incontinence, Urge
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections Pro-Nox Nitrous Oxide/Oxygen Delivery System, Standard Care for Bladder Botox Injection, Sham Mask - Overactive Bladder, Neurogenic Bladder | Phase 4 | Not yet recruiting | TriHealth Inc. | 96 | 2026-02-01 | 2026-02-04 |
| Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women Low intensity shockwave therapy, Oral Solifenacin succinate 5 mg - Overactive Bladder (OAB), Urge Incontinence | Phase 4 | Recruiting | Mansoura University | 70 | 2025-11-11 | 2026-03-16 |
| Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study Tadalafil 5 mg, Solifenacin 5mg - Overactive Bladder (OAB), Overactive Bladder Syndrome | Phase 4 | Recruiting | Mansoura University | 480 | 2025-09-01 | 2026-02-18 |
| Prophylactic Analgesia for Bladder Botox Injections Phenazopyridine, 1% lidocaine with sodium bicarbonate - Urinary Incontinence, Urinary Incontinence, Urge | Phase 4 | Withdrawn | Montefiore Medical Center | 2025-07-01 | 2025-07-18 | |
| Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections Lidocaine 2% without vessel constrictor - Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Not yet recruiting | University of Louisville | 36 | 2024-12-01 | 2024-11-19 |
| Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women vaginal 17 beta-estradiol, Placebo, Behavioral modifications - Lower Urinary Tract Symptoms, Female Genitourinary Disease | Phase 4 | Completed | Mahidol University | 86 | 2024-04-08 | 2025-04-20 |
| Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection Single-Dose Antibiotic, Multi-Dose Antibiotic - Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Completed | The Cleveland Clinic | 100 | 2022-12-06 | 2024-01-02 |
| TReating Incontinence for Underlying Mental and Physical Health Tolterodine Tartrate ER, Mirabegron, Placebo - Urinary Incontinence, Urge, Urinary Incontinence | Phase 4 | Recruiting | University of California, San Francisco | 270 | 2022-10-04 | 2026-03-06 |
| Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial OnabotulinumtoxinA 100 UNT [Botox] - Overactive Bladder, Urinary Urge Incontinence | Phase 4 | Completed | University of California, Irvine | 116 | 2022-05-01 | 2026-02-25 |
| A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder mirabegron - Urge Incontinence, Overactive Bladder (OAB) | Phase 4 | Completed | Astellas Pharma China, Inc. | 249 | 2021-01-06 | 2024-11-15 |
| Minimizing Pain During Office Intradetrussor Botox Injection Bicarbonate protocol, Standard protocol - Overactive Bladder, Overactive Detrusor | Phase 4 | Completed | Boston Urogynecology Associates | 85 | 2020-08-15 | 2025-03-06 |
| Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A OnabotulinumtoxinA 100 UNT - Urinary Bladder, Overactive, Incontinence, Urge | Phase 4 | Recruiting | University of South Florida | 60 | 2019-10-09 | 2020-11-05 |
| Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder Anticholinergic, Beta-3 Agonists, Adrenergic, Functional magnetic resonance imaging (fMRI) - Overactive Bladder, Dementia | Phase 4 | Completed | Baylor Research Institute | 12 | 2019-08-05 | 2024-02-02 |
| Oral vs Intravesical Analgesia for Office Bladder Botox Injections Phenazopyridine, Lidocaine 2% Injectable Solution - Overactive Bladder Syndrome, Urge Incontinence | Phase 4 | Unknown | Women and Infants Hospital of Rhode Island | 110 | 2018-11-01 | 2020-05-29 |
| Treatment of Incontinence Without Memory Problems Mirabegron, Tolterodine Tartrate - Urge Incontinence, Urinary Incontinence, Urge | Phase 4 | Completed | University of California, San Francisco | 23 | 2016-02-01 | 2019-04-16 |
| Reduction of Bladder Injection Pain With Belladonna Opiate Suppository Onabotulinumtoxin A (BoNT), belladonna, Morphine - Overactive Bladder, Urinary Urge Incontinence | Phase 4 | Completed | Edgar LeClaire, MD | 26 | 2015-11-01 | 2018-09-20 |
| Comparison of Combination Therapy vs Single Agent Therapy for Treatment of Urge Incontinence. Oxybutynin extended release, Posterior Tibial Nerve Stimulation, Placebo - Urinary Urge Incontinence | Phase 4 | Terminated | Duke University | 55 | 2014-08-01 | 2018-01-23 |
| Incontinence & Intimate Partners: Assessing the Contribution of Treatment Solifenacin - Urge Urinary Incontinence | Phase 4 | Completed | Loyola University | 138 | 2012-03-09 | 2019-12-02 |
| Evaluating the Change of Overactive Bladder Symptoms in Women Post Pubovaginal Sling Procedure for Stress Incontinence Pubovaginal sling procedure - Urinary Bladder, Overactive | Phase 4 | Completed | Barrie Urology Associates | 132 | 2010-10-01 | 2012-09-20 |
| Athena Pelvic Muscle Trainer - DUETS Trial Athena Pelvic Muscle Trainer - Urinary Incontinence | Phase 4 | Completed | Athena Feminine Technologies, Inc. | 462 | 2010-02-01 | 2011-07-14 |
Showing 20 of 28. Sign in to see all of them.
Urinary Bladder, Overactive (24) · Urinary Incontinence (9) · Nocturia (3) · Urinary Bladder, Neurogenic (3) · Urinary Incontinence, Stress (3) · Agnosia (2) · Lower Urinary Tract Symptoms (2) · Cystitis, Interstitial (1) · Dementia (1) · Female Urogenital Diseases (1) · Pain (1) · Pelvic Floor Disorders (1) · Spasm (1)
Female Urogenital Diseases and Pregnancy Complications (28) · Male Urogenital Diseases (28) · Pathological Conditions, Signs and Symptoms (28) · Signs and Symptoms (28) · Urination Disorders (28) · Urogenital Diseases (28) · Urologic Diseases (28) · Urological Manifestations (28) · Female Urogenital Diseases (27) · Lower Urinary Tract Symptoms (26) · Urinary Bladder Diseases (24) · Urinary Incontinence (19) · Nervous System Diseases (6) · Neurologic Manifestations (5) · Neurobehavioral Manifestations (2)
Solifenacin Succinate (6) · Tolterodine Tartrate (6) · Lidocaine (4) · mirabegron (4) · Botulinum Toxins, Type A (3) · Phenazopyridine (2) · fesoterodine (2) · AIEOP acute lymphoblastic leukemia protocol (1) · Adrenergic beta-3 Receptor Agonists (1) · Anti-Bacterial Agents (1) · Antibiotic Prophylaxis (1) · Behavior Therapy (1) · Cholinergic Antagonists (1) · Estradiol (1) · Idoxuridine (1)
University of California, San Francisco (3) · Mansoura University (2) · Astellas Pharma China, Inc. (1) · Astellas Pharma Inc (1) · Athena Feminine Technologies, Inc. (1) · Barrie Urology Associates (1) · Baylor Research Institute (1) · Boston Urogynecology Associates (1) · Duke University (1) · Edgar LeClaire, MD (1) · Imperial College London (1) · Loyola University (1) · Mahidol University (1) · Montefiore Medical Center (1) · Novartis (1)
United States (19) · Belgium (2) · Egypt (2) · Israel (2) · Italy (2) · Spain (2) · Turkey (Türkiye) (2) · United Kingdom (2) · Australia (1) · Austria (1) · Canada (1) · China (1) · Czechia (1) · Denmark (1) · Finland (1)
Ahmed A Shokeir, professor of urology (1) · Alison Huang, MD, MAS, MPhil (1) · Carly Crowder, MD (1) · Edgar LeClaire, MD, FACOG (1) · Elizabeth Meuller, MD (1) · Emily Slopnick, MD (1) · Eric S Chang, MD (1) · Felicia Lane, MD (1) · Ilan Gruenwald, MD (1) · Jeanette S. Brown, MD (1) · Jill Danford, MD (1) · Joseph A Zadra, MD CM FRCSC (1) · Julia Shaw, MD (1)
PMID 37160401, PMID 37811598, PMID 23460503, PMID 29324595, PMID 35543540, PMID 35580634, PMID 37085880, PMID 40025238
R01AG075471 (1)